USA flag logo/image

An Official Website of the United States Government

FEASIBILITY STUDY TO PRODUCE HETEROGENOUS IMMUNOGLOBULIN

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
11064
Program Year/Program:
1989 / SBIR
Agency Tracking Number:
11064
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Hastings Labs
1030 N Parkview Dr Bismarck, ND 58501
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1989
Title: FEASIBILITY STUDY TO PRODUCE HETEROGENOUS IMMUNOGLOBULIN
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THIS RESEARCH WILL DETERMINE THE FEASIBILITY OF PRODUCING IMMUNOGLOBULINS AGAINST THE OPPORTUNISTIC ENTERIC INFECTIONSOF HIV-INFECTED NEONATES UTILIZING THE COLOSTRUM FROM HYPERIMMUNIZED COWS OR THE EGG YOLK IMMUNOGLOBULINS AVAILABLE FROM HYPERIMMUNIZED CHICKENS. THESE TWO COMMON DOMESTIC ANIMALS WOULD BE IMMUNIZED WITH THE LABORATORY ISOLATES FROM A MEDICAL CENTER TREATING AIDS NEONATES. HETEROGENEOUS IMMUNOGLOBULINS WOULD BE INEXPENSIVE TO PRODUCE. AS THEY ARE POLYCLONAL, THEY COULD BE USED FOR MANY PATHOGENS AND COULD BE EFFECTIVE WHEN TAKEN ORALLY. THEY WOULD NOT POSE A TOXICITY PROBLEM, AS OCCURS WITH SOME PHARMACEUTICALS. FAVORABLE RESULTS OF THIS STUDY COULD OFFER PREVENTIVE METHODS FOR PATIENTS IN UNDERDEVELOPED COUNTRIES. THE IMMUNOGLOBULINS PRODUCED FROM THIS RESEARCH WOULD BE AVAILABLE TO ANY MEDICAL INSTITUTION WISHING TO DO CLINICAL TRIALS.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

Hastings Labs
1030 N Parkview Dr Bismarck, ND 58501

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No